IL22 and polycystic ovary syndrome: Subsequent treatment of the mice displaying PCOS-like symptoms with glycocholic acid (GDCA) or IL-22 resulted in significant improvements in local ovarian inflammation, hormonal imbalances, irregular estrous cycles, polycystic ovary lesions, fertility challenges, and IR [46].